Description
Paliperidone is a centrally acting antagonist of dopamine, serotonin, H1-histamine, alpha1- and alpha2-adrenergic receptors. The drug is effective in the treatment of schizophrenia, schizoaffective, and manic-depressive disorders. According to some data, paliperidone may also be used in the treatment of autism and Asperger's syndrome.
Period of execution
Within 4 days. The specified time does not include the day of biomaterial collection
Biomaterial type